Tatva Chintan Pharma Chem Ltd
NSE:TATVA
Tatva Chintan Pharma Chem Ltd
NSE:TATVA
Price:
1 128.1
INR
-0.3%
Market Closed
Market Cap:
₹26.4B
Income Statement
Earnings Waterfall
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd
Income Statement
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd
Currency: INR
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
39
|
0
|
0
|
0
|
79
|
0
|
0
|
0
|
61
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
2 956
N/A
|
4 192
+42%
|
4 438
+6%
|
4 336
-2%
|
4 152
-4%
|
4 701
+13%
|
4 860
+3%
|
4 236
-13%
|
5 380
+27%
|
4 562
-15%
|
4 198
-8%
|
3 935
-6%
|
3 846
-2%
|
3 714
-3%
|
3 731
+0%
|
3 827
+3%
|
3 941
+3%
|
4 341
+10%
|
4 796
+10%
|
|
| Gross Profit | ||||||||||||||||||||
| Cost of Revenue |
(1 427)
|
(1 977)
|
(2 108)
|
(2 303)
|
(1 813)
|
(2 096)
|
(2 322)
|
(2 582)
|
(2 841)
|
(2 382)
|
(2 077)
|
(2 182)
|
(1 732)
|
(1 786)
|
(1 828)
|
(2 424)
|
(2 003)
|
(2 124)
|
(2 260)
|
|
| Gross Profit |
1 529
N/A
|
2 215
+45%
|
2 330
+5%
|
2 034
-13%
|
2 339
+15%
|
2 605
+11%
|
2 539
-3%
|
1 654
-35%
|
2 538
+53%
|
2 180
-14%
|
2 120
-3%
|
1 753
-17%
|
2 115
+21%
|
1 929
-9%
|
1 904
-1%
|
1 403
-26%
|
1 938
+38%
|
2 217
+14%
|
2 535
+14%
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(829)
|
(1 177)
|
(1 303)
|
(1 032)
|
(1 449)
|
(1 836)
|
(1 831)
|
(1 071)
|
(1 875)
|
(1 599)
|
(1 651)
|
(1 315)
|
(1 782)
|
(1 743)
|
(1 761)
|
(1 337)
|
(1 853)
|
(1 987)
|
(2 143)
|
|
| Selling, General & Administrative |
(210)
|
(285)
|
(296)
|
(948)
|
(323)
|
(426)
|
(449)
|
(974)
|
(502)
|
(465)
|
(507)
|
(1 059)
|
(559)
|
(548)
|
(533)
|
(1 060)
|
(543)
|
(563)
|
(599)
|
|
| Depreciation & Amortization |
(53)
|
(73)
|
(78)
|
(82)
|
(86)
|
(112)
|
(115)
|
(96)
|
(156)
|
(177)
|
(219)
|
(256)
|
(263)
|
(263)
|
(266)
|
(277)
|
(300)
|
(322)
|
(344)
|
|
| Other Operating Expenses |
(566)
|
(818)
|
(929)
|
(2)
|
(1 040)
|
(1 298)
|
(1 268)
|
(1)
|
(1 217)
|
(958)
|
(925)
|
(1)
|
(961)
|
(933)
|
(963)
|
(0)
|
(1 010)
|
(1 102)
|
(1 200)
|
|
| Operating Income |
700
N/A
|
1 038
+48%
|
1 026
-1%
|
1 002
-2%
|
890
-11%
|
769
-14%
|
707
-8%
|
583
-18%
|
664
+14%
|
581
-12%
|
470
-19%
|
437
-7%
|
333
-24%
|
186
-44%
|
143
-23%
|
67
-53%
|
86
+29%
|
230
+168%
|
392
+71%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
(36)
|
(48)
|
(47)
|
45
|
(44)
|
(56)
|
(74)
|
(114)
|
(113)
|
(120)
|
(95)
|
(7)
|
(39)
|
(11)
|
(11)
|
10
|
(14)
|
(17)
|
(18)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(36)
|
(36)
|
(36)
|
(36)
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
|
| Total Other Income |
46
|
74
|
114
|
(5)
|
90
|
95
|
63
|
14
|
68
|
41
|
38
|
7
|
77
|
73
|
61
|
1
|
27
|
33
|
50
|
|
| Pre-Tax Income |
710
N/A
|
1 064
+50%
|
1 094
+3%
|
1 041
-5%
|
936
-10%
|
809
-14%
|
696
-14%
|
448
-36%
|
582
+30%
|
467
-20%
|
377
-19%
|
436
+16%
|
370
-15%
|
247
-33%
|
192
-22%
|
76
-61%
|
99
+30%
|
246
+149%
|
424
+73%
|
|
| Net Income | ||||||||||||||||||||
| Tax Provision |
(58)
|
(88)
|
(99)
|
(82)
|
(110)
|
(139)
|
(138)
|
7
|
(32)
|
(8)
|
0
|
(132)
|
(109)
|
(71)
|
(50)
|
(19)
|
(27)
|
(68)
|
(97)
|
|
| Income from Continuing Operations |
651
|
976
|
995
|
959
|
825
|
670
|
558
|
455
|
550
|
459
|
377
|
304
|
260
|
176
|
143
|
57
|
72
|
177
|
328
|
|
| Net Income (Common) |
651
N/A
|
976
+50%
|
995
+2%
|
959
-4%
|
825
-14%
|
670
-19%
|
558
-17%
|
455
-19%
|
550
+21%
|
459
-17%
|
377
-18%
|
304
-19%
|
260
-14%
|
176
-32%
|
143
-19%
|
57
-60%
|
72
+25%
|
177
+148%
|
328
+85%
|
|
| EPS (Diluted) |
32.42
N/A
|
45.2
+39%
|
44.88
-1%
|
44.59
-1%
|
37.23
-17%
|
30.24
-19%
|
25.19
-17%
|
20.52
-19%
|
24.81
+21%
|
20.21
-19%
|
16.14
-20%
|
13.26
-18%
|
11.32
-15%
|
7.68
-32%
|
6.2
-19%
|
2.44
-61%
|
3.05
+25%
|
7.58
+149%
|
14.01
+85%
|
|
Switch to:
Switch to:
See Also
Discover More
